NorthShore University HealthSystem offers expanded access to treat most common prostate ailment
Highland Park Hospital adds second AquaBeam system, Swedish Hospital installs first EVANSTON, Ill., Aug. 16,…
Month: August 2023
NorthShore University HealthSystem offers expanded access to treat most common prostate ailment
Highland Park Hospital adds second AquaBeam system, Swedish Hospital installs first EVANSTON, Ill., Aug. 16,…
Cidara Therapeutics Announces Appointment of Nicole Davarpanah, M.D., J.D., as Senior Vice President of Translational Research & Development
Dr. Davarpanah will lead Cidara’s oncology efforts, focusing on strategy to advance development candidates Previously…
Cidara Therapeutics Announces Appointment of Nicole Davarpanah, M.D., J.D., as Senior Vice President of Translational Research & Development
Dr. Davarpanah will lead Cidara’s oncology efforts, focusing on strategy to advance development candidates Previously…
PDS Biotech Announces Data from IMMUNOCERV Phase 2 Trial Investigating PDS0101 and Chemoradiotherapy in Cervical Cancer to be Featured in Oral Presentation at the ASTRO 2023 Annual Meeting
Study evaluates the effect of combining PDS0101 with standard of care on levels of circulating…
PDS Biotech Announces Data from IMMUNOCERV Phase 2 Trial Investigating PDS0101 and Chemoradiotherapy in Cervical Cancer to be Featured in Oral Presentation at the ASTRO 2023 Annual Meeting
Study evaluates the effect of combining PDS0101 with standard of care on levels of circulating…
Soleno Therapeutics Announces Appointment of Industry Veteran Matthew Pauls, J.D., M.B.A. to Board of Directors
REDWOOD CITY, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO),…
Soleno Therapeutics Announces Appointment of Industry Veteran Matthew Pauls, J.D., M.B.A. to Board of Directors
REDWOOD CITY, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO),…
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
Day One receives an exclusive license to develop and commercialize small molecule drug candidates for…
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
Day One receives an exclusive license to develop and commercialize small molecule drug candidates for…
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and…
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and…
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
New addition expands reconstruction options for surgeons and patients MALVERN, Pa., Aug. 16, 2023 (GLOBE…
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
New addition expands reconstruction options for surgeons and patients MALVERN, Pa., Aug. 16, 2023 (GLOBE…
Tonix Pharmaceuticals Initiates Phase 1 Trial of TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers
Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500…
Tonix Pharmaceuticals Initiates Phase 1 Trial of TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers
Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500…
Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma
The 7,380,394 AEON shares reflected in the Form 4 filed on August 14th were transferred to limited partners of…
Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma
The 7,380,394 AEON shares reflected in the Form 4 filed on August 14th were transferred to limited partners of…
Mezmo Ranks #1,386 on Inc. 5000’s List of Fastest Growing Companies in the Nation
Company attributes 421% growth to demand for solutions that empower companies with trusted telemetry data…
Mezmo Ranks #1,386 on Inc. 5000’s List of Fastest Growing Companies in the Nation
Company attributes 421% growth to demand for solutions that empower companies with trusted telemetry data…